Stoke therapeutics inc.

NA

STOK


Executive/
Director

Price

  • Last Close
  • $ 11.5
    $ +0.23 2 %
    Jan 3, 2025
  • 52-Week High/Low
  • $17.53 - $3.37
  • YTD
  • 3.9%

  • Trading Volume
  • 11,461
  • Market Cap Full
  • $ 513.5M
  • Shares Outstanding
  • 44.7M
    Oct 30, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - - -5% -37.9% -12.3% -9.8% 157% 3.9%
Q2 - - - - 4% -12.5% -37.2% 27.6% -1.4% -
Q3 - - - -23.8% 8% -24.4% -2.8% -62.9% -3.5% -
Q4 - - - 31.8% 84.9% -5.6% -28.1% 42.6% -19.7% -
J F M A M J J A S O N D
2025 3.9% - - - - - - - - - - -
2024 -8% 59.9% 74.7% -10.7% 20.8% -8.8% - - - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%0%119%-61%-62%-43%110%4%

Earnings

2016 2017 2019 2021 2022 2023
Q1 - - - -0.46 -0.66 -0.53
Q2 - - 1.54 -0.6 -0.63 -0.69
Q3 - - 0.26 -0.61 -0.66 -0.55
Q4 - - - -0.67 -0.65 -
A 0 0 1.8 -2.3 -2.6 -1.77

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2019 2020 2021 2022 2023
Mar - 32.9 36.7 37.4 44.1
Jun - 33 36.7 39.2 44.2
Sep 32.7 33.2 36.7 39.4 44.3
Dec 32.7 33.5 36.8 39.4 44.7

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 1.5 - - - -
Total Asset Turnover 0.1 - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 34.7 - 53 9 -
Equity multiplier - - - - -